Loading...
The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C
BACKGROUND: It has been found that ITPase deficiency is caused by ITPA gene polymorphisms. It was observed that ITPA polymorphisms have impact on hematological changes, including hemoglobin (Hb)-decline during treatment of chronic hepatitis C (CHC) patients with pegylated-interferon (PEG-IFN) plus r...
Na minha lista:
| Udgivet i: | Hepat Mon |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Kowsar
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851836/ https://ncbi.nlm.nih.gov/pubmed/27148387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.35278 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|